• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Arch Virol . Identification and characterization of a marine bacterium extract from Mameliella sp. M20D2D8 with antiviral effects against influenza

tetano

Editor, Senior Moderator
Arch Virol


. 2024 Feb 7;169(3):41.
doi: 10.1007/s00705-024-05979-8. Identification and characterization of a marine bacterium extract from Mameliella sp. M20D2D8 with antiviral effects against influenza A and B viruses

Hyo-Jin Kim[SUP] #[/SUP][SUP] 1 [/SUP], Jun-Gyu Park[SUP] #[/SUP][SUP] 2 [/SUP], Kyeong-Seo Moon[SUP] 1 3 [/SUP], Su-Bin Jung[SUP] 1 3 [/SUP], Yong Min Kwon[SUP] 4 [/SUP], Nam Seon Kang[SUP] 4 [/SUP], Jeong-Hyeon Kim[SUP] 5 [/SUP], Sang-Jip Nam[SUP] 5 [/SUP], Grace Choi[SUP] 6 [/SUP], Yeong-Bin Baek[SUP] 7 [/SUP], Sang-Ik Park[SUP] 8 9 [/SUP]



Affiliations
Free article Abstract

Despite significant improvements in vaccines and chemotherapeutic drugs, pathogenic RNA viruses continue to have a profound impact on the global economy and pose a serious threat to animal and human health through emerging and re-emerging outbreaks of diseases. To overcome the challenge of viral adaptation and evolution, increased vigilance is required. Particularly, antiviral drugs derived from new, natural sources provide an attractive strategy for controlling problematic viral diseases. In this antiviral study, we discovered a previously unknown bacterium, Mameliella sp. M20D2D8, by conducting an antiviral screening of marine microorganisms. An extract from M20D2D8 exhibited antiviral activity with low cytotoxicity and was found to be effective in vitro against multiple influenza virus strains: A/PR8 (IC[SUB]50[/SUB] = 2.93 µg/mL, SI = 294.85), A/Phil82 (IC[SUB]50[/SUB] = 1.42 µg/mL, SI = 608.38), and B/Yamagata (IC[SUB]50[/SUB] = 1.59 µg/mL, SI = 543.33). The antiviral action was found to occur in the post-entry stages of viral replication and to suppress viral replication by inducing apoptosis in infected cells. Moreover, it efficiently suppressed viral genome replication, protein synthesis, and infectivity in MDCK and A549 cells. Our findings highlight the antiviral capabilities of a novel marine bacterium, which could potentially be useful in the development of drugs for controlling viral diseases.

Keywords: Apoptosis; Broad-spectrum therapeutics; Influenza virus; Mameliella sp.; Marine extract.

 
Back
Top